|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
0.300 0.000 (0.000%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 124,455 | -40.034% | 207,542 | 144,606 | 160,925 | 155,363 |
| Cost of Sales | (39,507) | -30.421% | (56,780) | (30,662) | (56,207) | (121,080) |
| Gross Profit | 84,948 | -43.654% | 150,762 | 113,944 | 104,718 | 34,283 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (26,726) | 137.375% | (11,259) | (1,452) | (9,709) | (38,541) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (210) | (400) | (573) | 780 | |
| Profit / (Loss) before Taxation | (68,031) | 92.069% | (35,420) | 2,497 | (69,143) | (172,683) | |
| Taxation | (307) | -50.958% | (626) | (898) | (1,311) | (396) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 3,752 | 6,448 | 9,693 | 21,210 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (68,338) | 111.612% | (32,294) | 8,047 | (60,761) | (151,869) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 1,701 | -- | (402) | 1,129 | 1,568 | 3,007 |
| Depreciation & Amortisation | 15,539 | 9.754% | 14,158 | 12,017 | 13,763 | 24,414 |
| Directors' Emoluments | 9,372 | -8.485% | 10,241 | 8,624 | 9,507 | 10,218 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Disclaimer | -- | Disclaimer | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -28.000 | 115.385% | -13.000 | 3.000 | -26.000 | -71.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | 0.054 | (0.021) | 0.001 |
| NBV per share ($) | (0.265) | -- | 0.007 | 0.132 | 0.095 | 0.047 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 20,596 |
| %Change | -- |
| EPS / (LPS) | HKD 0.080 |
| NBV Per Share ($) | HKD -0.201 |